http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Senftleben, Stephan (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
Baum, Richard P.,Kluge, Andreas,Gildehaus, Franz Josef,Bronzel, Marcus,Schmidt, Karl,Schuchardt, Christiane,Senftleben, Stephan,Samnick, Samuel The Korea Society of Nuclear Medicine 2011 핵의학 분자영상 Vol.45 No.4
Purpose To explore feasibility, tolerability, dosimetry and probable efficacy of intravenous endoradiotherapy with carrier-added 4-[$^{131}I$]iodo-L-phenylalanine (c.a. $^{131}I$-IPA) in refractory high-grade glioma. Methods Two male patients (45 and 50 years), with longstanding, extensively pre-treated gliomas and evidence of progression underwent single intravenous injections of 2 and 4 GBq of c.a. $^{131}I$-IPA, respectively. Tumour targeting was verified by $^{131}I$-IPA single-photon emission computed tomography (SPECT). Metabolic and morphological changes indicative of tumour response were assessed by sequential [$^{18}F$] fluoroethyltyrosine ($^{18}F$-FET) positron emission tomography (PET) and contrast-enhanced magnetic resonance imaging (MRI) following therapy. Further monitoring included clinical state, safety laboratory, quality of life and dosimetry. Absorbed mean organ and whole-body doses were determined according to the Medical Internal Radiation Dose (MIRD) scheme using OLINDAEXM based on serial planar scintigraphy. Results Both patients tolerated the treatment well. No evidence of acute or delayed organ toxicity was observed. $^{131}I$-IPA accumulated in the tumour recurrences identified by MRI/$^{18}F$-FET. In patient 1, PET showed progressively decreasing maximum standardised uptake values ($SUV_{max}$) over 10 months, indicating metabolic response, paralleled by reduced contrast enhancement and tumour volume on MRI. Progression occurred 18 months after therapy. Treatment was repeated using 6.6 GBq of $^{131}I$-IPA, to which no response was observed. Patient 2, followed-up for 3 months after therapy, showed stable disease on MRI and PET. Mean absorbed whole body doses ranged from 0.13 to 0.17 mSv/MBq, with the highest absorbed organ doses to kidneys, bladder and heart (0.86-1.23; 0.49-0.6 and 0.45-0.56 mSv/MBq). Conclusion Systemic endoradiotherapy using up to 6.6 GBq of c.a.$^{131}I$-IPA is not associated with clinically detectable toxicity. Measurable anti-tumour effects in gliomas were observed. $^{131}I$-IPA warrants further evaluation as glioma therapy.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
